DE69004882T2 - Flüssige Nitrofurantoinsuspension. - Google Patents

Flüssige Nitrofurantoinsuspension.

Info

Publication number
DE69004882T2
DE69004882T2 DE69004882T DE69004882T DE69004882T2 DE 69004882 T2 DE69004882 T2 DE 69004882T2 DE 69004882 T DE69004882 T DE 69004882T DE 69004882 T DE69004882 T DE 69004882T DE 69004882 T2 DE69004882 T2 DE 69004882T2
Authority
DE
Germany
Prior art keywords
nitrofurantoin
suspension
liquid
monohydrate
particulates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69004882T
Other languages
English (en)
Other versions
DE69004882D1 (de
Inventor
Margaret Anne Mcgowan
Vijay Shahi
Michael John Kane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Eaton Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharmaceuticals Inc filed Critical Norwich Eaton Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69004882D1 publication Critical patent/DE69004882D1/de
Publication of DE69004882T2 publication Critical patent/DE69004882T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DE69004882T 1989-07-25 1990-07-18 Flüssige Nitrofurantoinsuspension. Expired - Fee Related DE69004882T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/385,646 US5178880A (en) 1989-07-25 1989-07-25 Liquid suspensions of nitrofurantoin

Publications (2)

Publication Number Publication Date
DE69004882D1 DE69004882D1 (de) 1994-01-13
DE69004882T2 true DE69004882T2 (de) 1994-05-19

Family

ID=23522290

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69004882T Expired - Fee Related DE69004882T2 (de) 1989-07-25 1990-07-18 Flüssige Nitrofurantoinsuspension.

Country Status (11)

Country Link
US (1) US5178880A (de)
EP (1) EP0410517B1 (de)
AT (1) ATE97806T1 (de)
AU (1) AU635948B2 (de)
CA (1) CA2020812C (de)
DE (1) DE69004882T2 (de)
DK (1) DK0410517T3 (de)
ES (1) ES2060931T3 (de)
IE (1) IE63814B1 (de)
IL (1) IL95059A (de)
NZ (1) NZ234635A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776343B1 (en) * 1999-02-17 2010-08-17 Csl Limited Immunogenic complexes and methods relating thereto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE515245A (de) * 1950-05-29
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form

Also Published As

Publication number Publication date
DK0410517T3 (da) 1994-02-07
IE63814B1 (en) 1995-06-14
CA2020812A1 (en) 1991-01-26
AU635948B2 (en) 1993-04-08
EP0410517B1 (de) 1993-12-01
CA2020812C (en) 1995-08-01
ATE97806T1 (de) 1993-12-15
NZ234635A (en) 1993-10-26
AU5975290A (en) 1991-01-31
US5178880A (en) 1993-01-12
DE69004882D1 (de) 1994-01-13
EP0410517A1 (de) 1991-01-30
ES2060931T3 (es) 1994-12-01
IL95059A0 (en) 1991-06-10
IL95059A (en) 1994-07-31
IE902693A1 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
MX173949B (es) Composiciones biocidas y agroquimicas
FR2531857B1 (fr) Composition injectable pour prolonger la stabilite et la retention de particules enrobees, injectees dans le flux sanguin d'animaux et d'etres humains
FI945081A0 (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
DE3485843T2 (de) Sucralfat-suspension zur verwendung in der behandlung von geschwueren.
DK486189D0 (da) Psyllium-froeskaller og midler omfattende samme
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
DE59002861D1 (de) Verwendung von wasserlöslichen copolymerisaten aus monoethylenisch ungesättigten carbonsäuren und vinylimidazol(derivaten) als wasserbehandlungsmittel.
DE69004882D1 (de) Flüssige Nitrofurantoinsuspension.
ATE33760T1 (de) Mittel zur oertlichen anwendung am koerper.
EP0129891A3 (de) Chinazolinon-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
IT8522027A0 (it) Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria.
DE69020257D1 (de) Nitrofurantoinkristalle.
FR2674437B1 (fr) Composition pharmaceutique, utile notamment dans le traitement d'affections gastro-óoesophagiennes.
SE8302789D0 (sv) Oral tandvardskomposition
FR2601950B1 (fr) N,n-dimethyl-n'-benzoyl-n' ((2,3-dihydro) benzofuran-2-yl-methyl) 1,3-propanediamine, preparation et compositions pharmaceutiques les contenant
ES2139881T3 (es) Formulacion acuosa de liberacion retardada.
DE68924316D1 (de) Menschliches Gamma-Interferon, Verfahren zu seiner Herstellung und seine Verwendung.
FR2556592B1 (fr) Compositions pharmaceutiques contenant des derives de l'acide campho-methylidene cinnamique
FR2541114B1 (fr) Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole
DE3784650D1 (de) Vorbeugende massnahmen zur verhinderung der "komplexen respiratorischen erkrankung bei rindern" durch verabreichung von interferon.
CO4290342A1 (es) Composiciones orales que contienen un agente quelador y un agente tensoactivo anionico hidrofobo en un vehiculo oral adecuado

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PROCTER & GAMBLE PHARMACEUTICALS, NORWICH, N.Y., U

8339 Ceased/non-payment of the annual fee